Raw Data on Patents referring to SARS-CoV and SARS-CoV-2
收藏官方服务：
资源简介：
Dataset related to the search of technologies available on SARS-CoV and ACE2, which may be applied to SARS-CoV-2
应用场景：
创建时间：
2020-04-20
相关数据集
Single-dose replicon RNA Sudan virus vaccine uniformly protects female guinea pigs from disease
The Sudan virus (SUDV) outbreaks in Uganda in 2022 and 2025 created public health concerns in-country and the entire East African region. There are currently no licensed countermeasures against SUDV.
Figshare2025-04-22 更新90
DataSheet_1_Neutralizing Potency of Prototype and Omicron RBD mRNA Vaccines Against Omicron Variant.pdf
The newly emerged Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) contains more than 30 mutations on the spike protein, 15 of which are located within the receptor bind
NIAID Data Ecosystem30
Single-dose replicon RNA Sudan virus vaccine uniformly protects female guinea pigs from disease
The Sudan virus (SUDV) outbreaks in Uganda in 2022 and 2025 created public health concerns in-country and the entire East African region. There are currently no licensed countermeasures against SUDV.
Figshare2025-04-10 更新30
Recombinant Chimeric Yellow Fever-Dengue Type 2 Virus Is Immunogenic and Protective in Nonhuman Primates
A chimeric yellow fever (YF)-dengue type 2 (dengue-2) virus (ChimeriVax-D2) was constructed using a recombinant cDNA infectious clone of a YF vaccine strain (YF 17D) as a backbone into which we insert
PubMed Central80
West Nile Virus Recombinant DNA Vaccine Protects Mouse and Horse from Virus Challenge and Expresses In Vitro a Noninfectious Recombinant Antigen That Can Be Used in Enzyme-Linked Immunosorbent Assays
Introduction of West Nile (WN) virus into the United States in 1999 created major human and animal health concerns. Currently, no human or veterinary vaccine is available to prevent WN viral infection
PubMed Central30
